New York Stem Cell Foundation announces $10.5 million to 7 new NYSCF-Robertson Investigators

The New York Stem Cell Foundation (NYSCF) today named seven of the most promising scientists as its 2013 NYSCF – Robertson Investigators.

Each Investigator will receive a $1.5 million award, which will be disbursed over the next five years, which will enable them to expand their laboratories and train other scientists. Three of the scientists were named NYSCF – Robertson Stem Cell Investigators, a program in its fourth year, and four were named NYSCF – Robertson Neuroscience Investigators, a program in its third year.

"These young Investigators are on the cutting-edge of high-risk, high-reward research that no one else is doing. We are all honored to support the careers and future investigations of these promising talents," said Susan L. Solomon, Chief Executive Officer of NYSCF.

The latest Investigators were announced at NYSCF's Eighth Annual Translational Stem Cell Research Conference, held at The Rockefeller University in Manhattan.

Designed to support scientists engaged in novel neuroscience and cutting-edge translational stem cell research, the two Investigator programs were created to aid talented researchers as they make the transition from the post doctoral phase of their careers to the establishment of their own laboratories.

The Investigator awards build on the previous success of NYSCF's Postdoctoral Fellowship program, which is the largest program of postdoctoral support for stem cell researchers in the United States, and has provided funding for 40 postdoctoral researchers to date.

Marc Tessier-Lavigne, PhD, President of The Rockefeller University, chaired the NYSCF – Robertson Neuroscience Investigator program's selection committee.

"It was again a very difficult decision to choose the investigators, but we are thrilled to be able to award these talented scientists and support their future work," said Dr. Tessier-Lavigne. "We are looking forward to the groundbreaking discoveries they will make in the field of neuroscience."

Tessier-Lavigne was joined on the jury by Anders Björklund, MD, PhD, Professor of Histology at the Wallenberg Neuroscience Center, University of Lund in Sweden; Catherine Dulac, PhD, Professor of Molecular and Cellular Biology and Howard Hughes Medical Institute Investigator at Harvard University; and, Lorenz Studer, MD, Director of Sloan-Kettering Center for Stem Cell Biology.

The NYSCF – Robertson Stem Cell Investigator program's selection committee consisted of Fiona Watt, DPhil, from King's College London in the United Kingdom; Lorenz Studer, MD, Director of the Sloan-Kettering Center for Stem Cell Biology; Irving Weissman, MD, Director of the Institute for Stem Cell Biology and Regenerative Medicine at the Stanford School of Medicine; and, Pete Coffey, DPhil, Co-Executive Director of Translation UC Santa Barbara's Center for Stem Cell Biology and Engineering and Director of the London Project to Cure Blindness, University College London.

"I'm happy we could select these early career scientists to support their future endeavors. This group has the potential to make new discoveries that may revolutionize our therapeutic approaches to diseases," said Fiona Watt.

The new NYSCF – Robertson Stem Cell Investigators are:

• Kristen Brennand, PhD, Assistant Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. Dr. Brennand's research focuses on how neurons affected by schizophrenia differ from healthy neurons in order to better understand the causes of the disorder, and in the hope that this may one day lead to new potential therapies.
• Jacob (Yaqub) Hanna, MD, PhD, Senior Scientist in the Department of Molecular Genetics at the Weizmann Institute of Science in Israel. Dr. Hanna explores topics in embryonic stem cell biology, early embryonic development, and the modeling of human diseases. His projects include deciphering the mechanisms by which induced pluripotent stem (iPS) cells are produced and characterizing unique types of human iPS cells and their various stages in early human development. Dr. Hanna's research holds the potential to create powerful research models for degenerative and autoimmune diseases such as type 1 diabetes.
• Jay Rajagopal, MD, Assistant Professor at the Center for Regenerative Medicine at Massachusetts General Hospital and the Harvard Stem Cell Institute. Dr. Rajagopal's research focuses on the application of stem cell and regenerative biology to human lung disease. His lab's inquiries into the molecular mechanisms underlying adult lung epithelial regeneration will serve as a framework with which to understand how the distortion of normal developmental processes results in human lung disease, specifically cystic fibrosis.

The new NYSCF – Robertson Neuroscience Investigators are:

Provided by New York Stem Cell Foundation